Lung transplantation is the most effective modality for the treatment of patients with end-
stage lung diseases. Unfortunately, many people cannot benefit from this therapy due to
insufficient donor availability. In this review and update article, we discuss donation after
circulatory death (DCD), which is undoubtedly essential among the strategies developed to
increase the donor pool. However, there are ethical and legislative considerations in the
DCD process that are different from those of donation after brain death (DBD). Among …

Lung transplantation (LTx) has become a standard therapy with growing activity over the
years that improves the quantity and the quality of life for selected patients suffering from end-
stage lung disease. 1 Unfortunately, not all lung transplant candidates can benefit because
of the lack of acceptable organs. Optimizing the lung donor pool should get utmost priority.
Besides improvement in current practices with better donor registration, detection, reporting,
and management, the use of alternative donors not matching the standard donor lung …